Inventor
Ying KONG
Inventor
CN
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium13%
C07KPeptides7%
PatentTitleYear
12,390,532ALK protein regulator and anti-tumor application thereof202512,226,424Target protein degradation compounds, their anti-tumor use, their intermediates and use of intermediates202511,771,709ALK protein degradation agent and anti-tumor application thereof202311,639,343Compounds targeting and degrading BCR-ABL protein and its antitumor application2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to UNIV SHANGHAI TECHNOLOGY (4)· patent assignee history
2023–2025Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV SHANGHAI TECHNOLOGY | 4 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 4 | 2023–2025 |